These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25499436)

  • 21. Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors.
    Fuchigami T; Haradahira T; Fujimoto N; Nojiri Y; Mukai T; Yamamoto F; Okauchi T; Maeda J; Suzuki K; Suhara T; Yamaguchi H; Ogawa M; Magata Y; Maeda M
    Bioorg Med Chem; 2009 Aug; 17(15):5665-75. PubMed ID: 19586774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
    J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Dosimetry of the
    van der Aart J; van der Doef TF; Horstman P; Huisman MC; Schuit RC; van Lingen A; Windhorst AD; van Berckel BNM; Lammertsma AA
    J Nucl Med; 2017 Aug; 58(8):1330-1333. PubMed ID: 28183990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
    Gao M; Mock BH; Hutchins GD; Zheng QH
    Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocator protein ligands based on N-methyl-(quinolin-4-yl)oxypropanamides with properties suitable for PET radioligand development.
    Brouwer C; Jenko KJ; Zoghbi SS; Morse CL; Innis RB; Pike VW
    Eur J Med Chem; 2016 Nov; 124():677-688. PubMed ID: 27622910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of
    Krämer SD; Betzel T; Mu L; Haider A; Herde AM; Boninsegni AK; Keller C; Szermerski M; Schibli R; Wünsch B; Ametamey SM
    J Nucl Med; 2018 Apr; 59(4):698-703. PubMed ID: 29191857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
    Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T
    Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of endogenous agonists, glycine and D-serine, on in vivo specific binding of [11C]L-703,717, a PET radioligand for the glycine-binding site of NMDA receptors.
    Haradahira T; Okauchi T; Maeda J; Zhang MR; Nishikawa T; Konno R; Suzuki K; Suhara T
    Synapse; 2003 Nov; 50(2):130-6. PubMed ID: 12923815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET studies of [18F]methyl-MK-801, a potential NMDA receptor complex radioligand.
    Blin J; Denis A; Yamaguchi T; Crouzel C; MacKenzie ET; Baron JC
    Neurosci Lett; 1991 Jan; 121(1-2):183-6. PubMed ID: 1826943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an automated, GMP compliant FASTlab™ radiosynthesis of [
    Khan I; Berg TC; Brown J; Bhalla R; Wilson A; Black A; McRobbie G; Nairne J; Olsson A; Trigg W
    J Labelled Comp Radiopharm; 2020 Apr; 63(4):183-195. PubMed ID: 31986223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
    Kirk CJ; Reddy NL; Fischer JB; Wolcott TC; Knapp AG; McBurney RN
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1080-5. PubMed ID: 7525936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased density, but not number, of N-methyl-D-aspartate, glycine and phencyclidine binding sites in hippocampus of senescent rats.
    Bonhaus DW; Perry WB; McNamara JO
    Brain Res; 1990 Nov; 532(1-2):82-6. PubMed ID: 2178039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, radiolabeling and evaluation of novel amine guanidine derivatives as potential positron emission tomography tracers for the ion channel of the N-methyl-d-aspartate receptor.
    Klein PJ; Chomet M; Metaxas A; Christiaans JA; Kooijman E; Schuit RC; Lammertsma AA; van Berckel BN; Windhorst AD
    Eur J Med Chem; 2016 Aug; 118():143-60. PubMed ID: 27128179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inorganic iron complexes derived from the nitric oxide donor nitroprusside: competitive N-methyl-D-aspartate receptor antagonists with nanomolar affinity.
    Neijt H; Koller M; Urwyler S
    Biochem Pharmacol; 2001 Feb; 61(3):343-9. PubMed ID: 11172739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, configuration, and activity of isomeric 2-phenyl-2-(N-piperidinyl)bicyclo[3.1.0]hexanes at phencyclidine and sigma binding sites.
    de Costa BR; Mattson MV; George C; Linders JT
    J Med Chem; 1992 Dec; 35(25):4704-12. PubMed ID: 1469699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Affinity of 1-aryl-1,2,3,4-tetrahydroisoquinoline derivatives to the ion channel binding site of the NMDA receptor complex.
    Ludwig M; Hoesl CE; Höfner G; Wanner KT
    Eur J Med Chem; 2006 Aug; 41(8):1003-10. PubMed ID: 16675066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors.
    Salabert AS; Fonta C; Fontan C; Adel D; Alonso M; Pestourie C; Belhadj-Tahar H; Tafani M; Payoux P
    Nucl Med Biol; 2015 Aug; 42(8):643-53. PubMed ID: 25963911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Radiolabeled Ligands Targeting the Glutamate Binding Site of the N-Methyl-d-aspartate Receptor as Potential Imaging Agents for Brain.
    Tamborini L; Chen Y; Foss CA; Pinto A; Horti AG; Traynelis SF; De Micheli C; Mease RC; Hansen KB; Conti P; Pomper MG
    J Med Chem; 2016 Dec; 59(24):11110-11119. PubMed ID: 28002957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facile radiosynthesis of new carbon-11-labeled propanamide derivatives as selective androgen receptor modulator (SARM) radioligands for prostate cancer imaging.
    Gao M; Wang M; Miller KD; Zheng QH
    Steroids; 2011 Dec; 76(13):1505-12. PubMed ID: 21867721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated production of a N-methyl-D-aspartate receptor radioligand [
    Yue X; Xin Y; Chugani HT; Chugani DC; Zhang S
    Appl Radiat Isot; 2019 Jun; 148():246-252. PubMed ID: 31026789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.